News & Insights

Tarsus Pharmaceuticals announces its definitive agreement to acquire Alkeus Pharmaceuticals, a privately held retinal disease-focused biotechnology company developing gildeuretinol (ALK-001), an investigational once-daily oral therapy for Stargardt disease.

Osanni Bio announces its $190 million Series B financing.

Urban SDK, a leading provider of geospatial AI solutions, announces its $65 million growth funding investment from Riverwood Capital.

Gunderson Dettmer was recognized as a winner in the 15^th Annual Mergers and Acquisitions Top Middle-Market Deals of the Year for its representation of Foresight Sports in its acquisition by Vista Outdoor and The Athletic in its acquisition by The New York Times, two out of the thirteen winning deals for the categories Media and Consumer Products and Outdoor Recreation.

Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP has elected six new partners, effective January 1. The elevations span the U.S. and add to the firm’s corporate and securities, venture and growth equity fund, public offerings/public companies, executive compensation and tax practices.